These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 22118358

  • 1. [Orgasm after curietherapy with permanent iodine-125 radioimplants for localized prostate cancer].
    Delaunay B, Delannes M, Salloum A, Delavierre D, Wagner F, Jonca F, Thoulouzan M, Plante P, Bachaud JM, Soulie M, Huyghe E.
    Prog Urol; 2011 Dec; 21(13):932-9. PubMed ID: 22118358
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sexual function after permanent 125I-brachytherapy for prostate cancer.
    Mabjeesh N, Chen J, Beri A, Stenger A, Matzkin H.
    Int J Impot Res; 2005 Dec; 17(1):96-101. PubMed ID: 15510186
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
    Mabjeesh NJ, Chen J, Stenger A, Matzkin H.
    Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
    [Abstract] [Full Text] [Related]

  • 8. Segmental dosimetry, toxicity and long-term outcome in patients with prostate cancer treated with permanent seed implants.
    Meyer A, Wassermann J, Warszawski-Baumann A, Baumann R, Machtens S, Karstens JH, Christiansen H, Merseburger A, Kuczyk MA, von Klot C.
    BJU Int; 2013 May; 111(6):897-904. PubMed ID: 23305079
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cross-sectional analysis of sexual function after prostate brachytherapy.
    Finney G, Haynes AM, Cross P, Brenner P, Boyn A, Stricker P.
    Urology; 2005 Aug; 66(2):377-81. PubMed ID: 16098365
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect on erectile function of 103palladium implantation for localized prostate cancer.
    Ponholzer A, Oismüller R, Somay C, Büchler F, Maier U, Hawliczek R, Rauchenwald M, Madersbacher S.
    BJU Int; 2005 Apr; 95(6):847-50. PubMed ID: 15794796
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Impact of neoadjuvant hormonal therapy on the permanent ¹²⁵I-seed brachytherapy for localized high-risk prostate cancer].
    Zhuang HY, Xu XM, Peng T, Lin CP.
    Zhonghua Yi Xue Za Zhi; 2010 Dec 28; 90(48):3418-20. PubMed ID: 21223817
    [Abstract] [Full Text] [Related]

  • 18. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N, Smolkin ME, Bissonette E, Theodorescu D.
    Cancer; 2005 Jun 15; 103(12):2499-506. PubMed ID: 15852361
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
    Teloken PE, Ohebshalom M, Mohideen N, Mulhall JP.
    J Urol; 2007 Dec 15; 178(6):2521-5. PubMed ID: 17937948
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.